Craig L. Slutzkin
@New Leaf Venture Partners, L.l.c.
Latest period2024 - Q3ReportedManaged Assets$97.295MTotal holdings10
Assets growth rate18.31%Assets growth rate (2-Q avg)-4.85%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in New Leaf Venture Partners, L.l.c.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 10 positions.
Assets under management
The assets under management (AUM) of New Leaf Venture Partners, L.l.c. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 97.295M in assets, with a quarterly growth rate of 18.31% and a 2-quarter average growth rate of -4.85%. The portfolio is managed by Craig L. Slutzkin, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
EWTXEdgewise Therapeutics Inc
| 42.62% | $41.467M 1.554M shares@ $26.69 avg price | |
ARVNArvinas Inc
| 36.32% | $35.337M 1.435M shares@ $24.63 avg price | Increased 11.26% |
CRNXCrinetics Pharmaceuticals Inc
| 7.41% | $7.205M 141,000 shares@ $51.1 avg price | |
RLYBRallybio Corporation
| 3.98% | $3.863M 3.302M shares@ $1.18 avg price | |
RCKTRocket Pharmaceuticals Inc
| 2.87% | $2.784M 150,706 shares@ $18.48 avg price | |
COGTCogent Biosciences Inc.
| 2.79% | $2.708M 250,765 shares@ $10.8 avg price | |
PASGPassage Bio
| 1.8% | $1.749M 2.498M shares@ $0.7 avg price | |
ALECAlector Inc
| 1.63% | $1.582M 339,569 shares@ $4.67 avg price | |
ITRMIterum Therapeutics Plc
| 0.39% | $376,072 345,020 shares@ $1.1 avg price | Increased 255.38% |
XFORX4 Pharmaceuticals Inc
| 0.24% | $224,115 335,000 shares@ $0.67 avg price |